This booklet breaks down common myths about clinical trials in psoriatic disease and explains why diversity and inclusion in research matter. It highlights the barriers many people face when accessing clinical trials, clarifies how trials work, and calls for more representative research that reflects the real-world psoriatic disease community.
Breaking The Myths: Clinical trials and psoriatic disease
27 April 2026
By IFPA
Related content
tool Advocacy, Toolkits
Design it right: A checklist for diverse, equitable, patient-first trials
tool Advocacy, Toolkits
Glossary: Common terms in clinical research
tool Advocacy, Toolkits
Before you join a study: A practical guide for participation in clinical trials
Article Advocacy, News
“Health right is a human right”
Article Advocacy, News
“We want to raise awareness and break stigma around psoriasis in Paraguay”
Article Advocacy, News
Patient organizations are crucial to achieving equitable healthcare globallytool Advocacy, IFPA Forum
IFPA Forum Africa Briefing Book